We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Study Supports Body Area Sensory Networks for Diagnostic Monitoring

By LabMedica International staff writers
Posted on 26 Aug 2019
The first steps have been taken on the path leading to development of a body area sensor network, which is a collection of networked sensors that can be used to remotely monitor human physiological signals.

For its application in next-generation personalized healthcare systems, stretchable on-skin sensors have to be seamlessly meshed with rigid silicon readout circuits. More...
Toward this end, investigators at Stanford University (Palo Alto, CA, USA) devleoped a body area sensory network (a bodyNET) composed of chip-free and battery-free stretchable on-skin sensor tags that were wirelessly linked to flexible readout circuits attached to clothing. This design offered a conformal skin-mimicking interface by removing all direct contacts between rigid components and the human body. Thus, this design addressed the mechanical incompatibility issue between soft on-skin devices and rigid high-performance silicon electronics.

For communications between the skin sensors and the clothing-bound receivers, the investigators introduced an unconventional radiofrequency identification technology where the wireless sensors were deliberately detuned to increase the tolerance of strain-induced changes in electronic properties. Thus, the bodyNET comprised chip-free and battery-free stretchable on-skin sensor tags, which had been screen-printed with metallic ink, that were wirelessly linked to flexible readout circuits attached to textiles.

The investigators used this prototype bodyNET to simultaneously and continuously analyse an individual’s pulse, breath, and body movement.

Ultimately, it is intended that this technology evolve into a device that would be comfortable to wear and have no batteries or rigid circuits to prevent the body sensors from stretching and contracting with the skin in response to changes in the subject’s physiology.

"We think one day it will be possible to create a full-body skin-sensor array to collect physiological data without interfering with a person's normal behavior," said senior author Dr. Zhenan Bao, professor of chemical engineering at Stanford University.

The bodyNET concept was discussed in a paper published in the August 15, 2019, online edition of the journal Nature Electronics.

Related Links:
Stanford University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.